Entera Bio Ltd (ENTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,593 | 15,185 | 7,506 | 11,746 | N/A |
| Marketable Securities | N/A | N/A | 4,015 | N/A | N/A |
| Receivables | 255 | 278 | 725 | N/A | N/A |
| Other current assets | 261 | 173 | 220 | 671 | 0 |
| TOTAL | $9,109 | $15,636 | $12,466 | $12,417 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 192 | 202 | 224 | 207 | N/A |
| Intangibles | 47 | 605 | 651 | 654 | 0 |
| Other Non-Current Assets | 374 | 260 | 0 | 0 | 0 |
| TOTAL | $613 | $1,067 | $875 | $861 | $N/A |
| Total Assets | $9,722 | $16,703 | $13,341 | $13,278 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,494 | 1,704 | 1,563 | 2,020 | 0 |
| Other current liabilities | 158 | 2,711 | 1,597 | N/A | N/A |
| TOTAL | $1,841 | $4,592 | $3,160 | $2,020 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 371 | 192 | 65 | 42,816 | 0 |
| TOTAL | $371 | $192 | $65 | $42,816 | $N/A |
| Total Liabilities | $2,212 | $4,784 | $3,225 | $44,836 | $N/A |
| Shareholders' Equity | |||||
| Retained earnings | -70,239 | -62,912 | -52,117 | -41,813 | N/A |
| Other shareholders' equity | 41 | 11,439 | 13,060 | 7,402 | 0 |
| TOTAL | $7,510 | $11,919 | $10,116 | $-31,558 | $N/A |
| Total Liabilities And Equity | $9,722 | $16,703 | $13,341 | $13,278 | $0 |